Sponsor pipeline

Doma Biopharmaceutical（Suzhou）Co., Ltd. clinical trial pipeline

Get alerts when Doma Biopharmaceutical（Suzhou）Co., Ltd.'s trials change

1 active trials 1 recruiting 1 disease areas 5 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-08
Primary completion pushed: 2026-10 → 2027-03
Phase changed: Phase 1 → Phase 1/2
Enrollment increased: 136 → 208 participants
Completion pushed: 2027-03 → 2027-09
Trial arms changed: 6 → 9
NCT06515990 A Study of DM005 in Patients With Advanced Solid Tumors · Phase 1/2

Active trials by phase

Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT06515990 A Study of DM005 in Patients With Advanced Solid Tumors Carcinoma, Non-Small-Cell Lung Recruiting 2026-08-07

Disease areas by active trials

Non-Small Cell Lung Cancer (NSCLC) (1)

Get alerts when Doma Biopharmaceutical（Suzhou）Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free